Skip to content

Thermo Fisher Scientific TMO Other accrued liabilities

Other accrued liabilities at other companies

Ecolab logo
EcolabECL
$1.77B+17.1%
WAT
Waters CorporationWAT
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
International Flavors & Fragrances logo
International Flavors & FragrancesIFF

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Operating income$1.9B+8.6%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.1%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%
Free cash flow$816.0M+126%

Valuation

See full
Market cap$172.66B-2.7%
Enterprise value$212.54B+0.9%
P/E25.2×-2.0×
P/S-0.8×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's other accrued liabilities?
Thermo Fisher Scientific (TMO) reported other accrued liabilities of $3.69B in Q1 2026.
How has Thermo Fisher Scientific's other accrued liabilities changed year-over-year?
Thermo Fisher Scientific's other accrued liabilities increased by 22.2% year-over-year, from $3.02B to $3.69B.
What is the long-term trend for Thermo Fisher Scientific's other accrued liabilities?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's other accrued liabilities has grown at a 7.5% compound annual growth rate (CAGR), from $2.31B to $3.33B.